|
[α−N-(2’succinyl-paclitaxel)Thr]-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-[ε−N-(2’succinyl-paclitaxel)Lys]-Arg-Asn-Asn-Phe-[ε−N-(2’succinyl-paclitaxel)Lys]-Thr-Glu-Glu-Tyr |
|---|---|
| Trade Name | |
| Orphan Indication | Breast cancer patients with brain metastases |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-15 00:00:00 |
| Sponsor | Angiochem, Inc.;201 President Kennedy, Montreal, Quebec H2X 3Y7; |
